h7n9-bird-flu-update-128-cases-26-deaths

H7N9 bird flu update- 130 cases, 32 deaths

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: National Health and Family Planning Commission, China, has notified the WHO of two additional laboratory-confirmed cases of human infection with avian... Read more

winners-of-glaxosmithkline-gsk-discovery-fast-track-competition-will-partner-with-investigators-on-gsk-s-discovery-partnerships-with-academia-dpac-team

GSK launches discovery competition for researchers

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GlaxoSmithKline (GSK) launched Discovery Fast Track, a competition designed to accelerate the translation of academic research into novel therapies. Winners... Read more

concord-medical-q1-2013-results-report-gross-profit-of-usd11

Chinese medtech firm Concord's revenue rise 91%

  • China
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Concord Medical Services reported its unaudited consolidated financial results for the first quarter ended March 31, 2013. The firm recorded total net... Read more

stemage-is-an-unique-natural-skin-rejuvenation-system-that-targets-visible-signs-of-aging-through-the-use-of-human-mesenchymal-stem-cell-derivatives

Stemcell-derived anti-aging product hits market

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ms Kathy Ireland, CEO and chief designer of kathy ireland Worldwide (kiWW) and Dr David Scharp, leading women's health advocate and world-renowned board... Read more

pfizer-stops-its-phase-iii-study-of-inotuzumab-ozogamicin

Pfizer halts 'useless' phase III lymphoma study

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pfizer has discontinued its phase III randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound... Read more

gorge-all-you-can-overeating-candy-or-sweets-dont-make-you-fat

Study: Eating candy or sweets dont make you fat

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study conducted by the Center for Chemical Regulation & Food Safety, which is part of US-based firm Exponent, has found that frequency of candy... Read more

adipose-tissue-derived-stem-cells-at-scs-are-better-performers-than-bone-marrow-derived-stem-cells

Stem cells from fat outperform those from bone marrow

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers at the Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands, have discovered that stem... Read more

alchemia-provides-update-on-fondaparinux-its-new-collaboration-with-merck-serono-and-its-current-ha-irinotecan-phase-iii-clinical-trial

Alchemia provides update on its core projects

  • Australia
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed drug fondaparinux; a new collaboration with... Read more

dr-jeremy-barr-led-the-team-of-researchers-at-san-diego-state-university-us-that-discovered-a-new-immune-system-where-bacteria-infecting-viruses-or-bacteriophages-shielded-the-body-from-invading-infection

Viruses in our mucus protect against infections

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A research team at the San Diego State University, US, led by Dr Jeremy Barr, post-doctoral fellow in biology, has discovered that mucus contained bacteria-infecting... Read more

globaldata-report-japan-s-branded-hronic-myeloid-leukemia-cml-therapeutics-market-will-grow-to-usd565-million-in-2022-at-a-cagr-of-1

Japan leukemia market to grow to $565mn in 2022

  • Japan
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by research and consulting firm GlobalData, highlighted that Japan's chronic myeloid leukemia (CML) market is going to witness a steady growth... Read more

astrazeneca-s-new-usd500-million-headquarters-will-be-located-at-the-south-of-cambridge

AstraZeneca to move HQ to $500 mn home in Cambridge

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca is looking to move its research and global headquarters to Cambridge, UK, and has zeroed in on a site located at the south of the city. The... Read more

biotech-2013-in-japan-was-held-from-may-8-10-2013-in-tokyo

Japan's BIOtech 2013 witnesses 10,362 visitors

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BIOtech 2013 in Japan, which is one-of-the-largest bio events in Asia, concluded successfully. The event was held in Tokyo, from May 8-10, 2013, and displayed... Read more

cx50-xmatrix-the-world-s-first-portable-ultrasound-with-philips-industry-leading-live-3d-tee-now-offers-2-d-intracardiac-echo-ice-capability

Philips launches world's first live 3D portable ultrasound...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Royal Philips Electronics' CX50 xMatrix, which is the world's first portable ultrasound featuring Philips' Live 3D TEE, is now offering 2-D Intracardiac... Read more

amgen-beta-pharmaceuticals-will-bring-colon-cancer-drug-vectibix-to-the-chinese-market

Amgen forms JV to launch cancer drug in China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will own 49 percent of interest.... Read more

analytica-gets-letter-of-intent-from-taiwan-allied-dragon-tad

Analytica to roll out auto start burettes in Taiwan

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Analytica secured a letter of intent from Taiwan's major medical products' distributor, Taiwan Allied Dragon (TAD), which will help roll out Analytica... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X